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ABSTRACT  The major excreted  protein (MEP) of transformed  mouse fibroblasts is a mannose 
6-phosphate-containing  glycoprotein  whose synthesis  and secretion are  increased  in  malig- 
nantly transformed  3T3 cells and whose synthesis  is increased  by treatment of 3T3 cells with 
tumor  promoters  or growth  factors.  When  pulse-labeled  extracts  from  Kirsten  virus-trans- 
formed  NIH  3T3  (KNIH) cells  were immunoprecipitated  using  an antibody against  secreted 
MEP, one cellular protein was immunoprecipitated  that had the same molecular weight and 
tryptic  peptide  map as the secreted  protein.  Pulse-chase  labeling experiments  showed that 
50-60%  of  this  39,000-mol-wt  form  was  secreted  in  transformed  cells.  Of  the  40-50% 
remaining,  ~5% was processed  into two lower molecular weight forms (29,000 and 20,000) 
which are sequestered within the cell.  Similar  processing of these proteins was observed  in 
the  nontransformed  parent  NIH  3T3  (NIH) cells.  However,  in  NIH  cells,  much  less of the 
synthesized  MEP was secreted.  Measurements of steady-state  levels  of these three forms of 
cellular MEP by Western blot immunolocalization  revealed approximately fourfold  more MEP 
in KNIH cells than in NIH cells as well as differences  in the relative distribution of MEP forms 
in transformed and nontransformed  cells.  Subcellular fractionation  of KNIH cells on a Percoll 
gradient demonstrated a distribution of total MEP similar to that of several lysosomal  enzymes. 
The  light  lysosomal/Golgi  peak from  these gradients  contained  both  the  precursor  39,000- 
mol-wt form  of MEP and  the  20,000-mol-wt  form,  whereas the  heavy  lysosomal  peak was 
enriched in the 20,000-mol-wt form. The distribution of MEP forms was found to be similar in 
NIH  cells  except  that the  29,000-mol-wt  form  was also  seen  to  be enriched  in  the  heavy 
lysosomal  peak.  This biochemical  localization  of MEP was confirmed  by immunolocalization 
with light and electron microscopy. These data support the hypothesis that MEP is a lysosomal 
protein that is secreted by transformed cells. 
There are significant differences between the proteins secreted 
by fibroblastic cells with  normal growth control  and those 
secreted  by  cells  that  are  malignantly  transformed.  The 
amounts of some secreted proteins, such as the extracellular 
matrix  proteins  collagen  (1)  and  fibronectin  (2),  decrease, 
whereas the protease plasminogen activator (3) increases after 
transformation.  It  has  been  suggested  that  these  protein 
changes may affect morphology and growth control  (4)  as 
well as invasiveness or metastasis of malignant fibroblasts. 
We have been studying the secretion of a  low molecular 
weight  protein,  MEP  (major  excreted  protein), j  by  trans- 
Abbreviations  used in  this paper:  CHO, Chinese hamster ovary; 
KNIH, Kirsten  virus-transformed  NIH  3T3  (cells); MEP, major 
excreted protein; NIH, NIH 3T3 (cells). 
formed murine fibroblasts. Increased MEP secretion was first 
observed in  Kirsten  sarcoma virus-transformed  NIH  3T3 
fibroblasts  (KNIH  cells).  The  secretion  of this  protein  is 
increased 50- to  100-fold  in these cells versus the NIH 3T3 
(NIH) parent cell line (5). Various agents induce an increase 
in the synthesis and/or secretion of MEP: other tumor viruses 
(Harvey and Moloney sarcoma viruses and SV-40 [5]), phor- 
bol ester tumor promoters (6, 7), and growth factors (platelet- 
derived growth factor [8] and fibroblast growth factor [9]). In 
mouse fibroblasts transformed virally or treated with tumor 
promoters, it has been shown that increased secretion of MEP 
is accompanied by a  concomitant increase  in  the  level of 
translatable MEP mRNA (6). 
Although a  function for MEP is not known, recent work 
has suggested that MEP has some properties in common with 
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coprotein (10) whose release  can be stimulated in nontrans- 
formed Balb/c 3T3 cells (9) and Chinese hamster ovary cells 
by NH4C1 (G.  G.  Sahagian, National Institute of Arthritis, 
Diabetes,  Digestive and Kidney Diseases;  personal commu- 
nication)--properties shared by the lysosomal enzymes.  Sa- 
hagian and Gottesman (11) have shown that the phosphate 
associated  with this protein is present as mannose 6-phos- 
phate. These residues allow binding of MEP to the phospho- 
mannosyl receptor (11),  which  is  required  for targeting of 
lysosomal enzymes to lysosomes in cultured fibroblasts  (12). 
These data suggest that MEP is either an unusual lysosomal 
protein which is secreted in transformed ,cells or a mannose 
6-phosphate-containing secretory protein. In this study, we 
find that the intracellular processing and the subcellular lo- 
calization of MEP indicate it is a lysosomal protein. We find 
that MEP is processed within both nontransformed and trans- 
formed cells into two lower molecular weight forms. Gradient 
fractionation of subcellular organdies demonstrates the pres- 
ence of nascent and processed MEP in the Golgi region of the 
gradient while the lower molecular weight forms of MEP are 
found in the lysosomal peak. The localization of MEP in the 
Golgi complex and lysosomes has been confirmed by indirect 
immunofluorescence and electron microscopic localization. 
MATERIALS  AND  METHODS 
Cell Culture:  NIH and KNIH cells obtained  from C. Scher (Harvard 
Medical School) were maintained  at 37"C in 5% CO2 in Dulbecco's modified 
Eagle's medium (HEM Laboratories, Rockville, MD) supplemented with pen- 
icillin (50  U/ml), streptomycin  (50 ug/ml),  and  10%  calf serum (Colorado 
Serum Co., Denver, CO). Cells were trypsinized with 0.25% trypsin (Micro- 
biological Associates, Walkersville, MD) in Tris-dextrose buffer (National  In- 
stitutes of Health  [NIH] media  unit). NIH cells were trypsinized with 0.25% 
trypsin and 0.2 mM EDTA in Tris-dextrose buffer. 
Labeling  and  Immunoprecipitation  of  Labeled  Pro- 
teins:  Monolayer cultures were labeled with either [35S]methionine or [35S]- 
cysteine (20-50  uCi/ml) in  Dulbecco-Vogt medium lacking the  appropriate 
amino acid (NIH media unit). For pulse-chase experiments, the labeling me- 
dium was replaced with normal growth  medium to begin the chase period. 
Cells were lysed on the dishes with SDS-Buffer A (0.154 M NaC1, 0.05 M Tris- 
HCI, pH 7.4, 0.5% Nonidet  P-40, 0.05% SDS), and lysates were clarified by 
centrifugation at  12,000 g for 2 min. Immunoprecipitation  of labeled protein 
was performed  using Staphylococcus aureus as previously described (19). The 
pellets were treated with SDS dissociation buffer (see below) and boiled before 
electrophoresis. 
SD5 PAGE:  Samples dissolved in SDS dissociation buffer (2.5% SDS, 
10% glycerol, 5% 2-mercaptoethanol,  and 0.0625 M~Tris-HCI, pH 6.8) were 
boiled 3 min and clarified by centrifugation at 12,000 g for 2 min. Electropho- 
resis was performed as described by Laemmli (13) except that the separating 
gel contained  10% glycerol and 0.5% linear acrylamide (14). For the determi- 
nation of molecular weight, SDS polyacrylamide gels were cast without glycerol 
or linear acrylamide at three different acrylamide concentrations ( 10, 12.5, and 
15 %). Stained gels were prepared for fluorography after destaining as described 
by Bonner and Laskey (15). The gels were exposed to preflashed X-Omat AR 
film (Kodak)  at -70"C; radioactivity  was quantitated  by densitometry  on a 
Joyce-Loebel 3CS microdensitometer  (Joyce-Loebel, Gateshead, England) and 
the peak areas were measured with an electronic planimeter (Numonics Corp., 
Lansdale,  PA) or by weighing excised peaks.  ~4C-Molecular weigi~,t markers 
(Amersham Corp., Arlington Heights, IL) for the gels were lysozyme (14,000 
tool  wt), carbonic  anhydrase  (30,000),  ovalbumin (46,000),  BSA  (69,000), 
phosphorylase b (92,500), and myosin (200,000). 
Tryptic Peptide Maps:  Gel bands of  proteins of interest were excised 
and two-dimensional tryptic peptide maps were performed as described by Shih 
et al. (16). The chromatography plates were dipped in 0.4% 2,5-diphenyloxazole 
in naphthalene  (17), allowed to cool, and exposed to x-ray film at -70"C. 
Percoll Gradients:  Cells  were grown to 70-80%  confluence in roller 
bottles (750 cm2), rinsed with PBS, and scraped off with a spatula. The cells 
were pelleted and resuspended  in gradient  buffer (0.25 M  sucrose, 20:mM 
HEPES, pH 7.0, 0.02% azide) at  1 x  107 cells/ml. The method of Rome et al. 
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(18) was used to obtain a postnuclear supernate. This method involves nitrogen 
cavitation to swell the cells and Dounce homogenization  to lyse them. Whole 
cells and nuclei were pelleted by centrifugation  at 600 g for 15 min.  5 ml of 
this supernate was loaded on 25 ml of 30% Percoll (Pharmacia Fine Chemicals, 
Piscataway, N  J) in gradient buffer over a 2-ml saturated sucrose cushion. The 
PercoU gradient  was formed  at  18,500 rpm (27,500 g) in a  Sorvall TV-850 
vertical rotor (E. I. DuPont de Nemours & Co., Inc., Sorvall Instruments Div., 
Newton, CT) for 1 h and  l-ml fractions were collected from the top. Density 
marker beads (Pharmacia  lnc.) were used to estimate the density profile of the 
gradient. 
Enzymatic and Protein Assays:  Lysosomal enzyme activities were 
determined by using the 4-methyl umbelliferyl substrates (1 mM) in 0.1 M Na 
acetate buffer, pH 4.4, in the presence of 0.1% Triton (18). Fluorescence was 
measured  on an Aminco-Bowman  spectrofluorometer  (Amicon Corp.,  Dan- 
vers, MA) with excitation beam set at 365 nm and emission beam at 455 nm. 
Results are given in arbitrary  fluorescence units. We assayed galactosyl trans- 
ferase by measuring the radioactivity transferred to N-acetyl glucosamine from 
UDP-[3H]galactose (12 Ci/mmol; New England Nuclear, Boston, MA) in  10 
mM Tris, 5 mM MnCI2, 1%  Triton  at 37"C (19). The nucleotide sugar was 
added at 4 x  105 cpm per 0.5-ml reaction, and N-acetyl glucosamine was at a 
concenlration  of 15 mM. We separated the precursor and product on a Dowex 
column (Dowex-l-chloride,  4% cross-linkage, 50-100 dry mesh; Sigma Chem- 
ical Co., St. Louis, MO) by rinsing the reaction  mixture through the column 
with water and determined  blank values by doing duplicate assays without N- 
acetyl glucosamine. Protein was analyzed by the method of Bradford (20) using 
ovalbumin as the standard. 
Western Blot Analysis:  Proteins were electrophoretically transferred 
to nitrocellulose paper from an SDS gel as described by Towbin et al. (21) in 
transfer buffer (25 mM Tris, 92 mM glycine, pH 8.3, 20% methanol). We used 
a Bio-Rad Trans-Blot chamber (Bio-Rad Laboratories, Richmond,  CA) at 200 
mA for 3 h. MEP was immunolocalized  using the technique  of Cabral et al. 
(22). The first antibody  was affinity purified on a MEP-Sepbarose column by 
the  method of Cabral  et  al.  (23). The second  antibody  was  nSl-Protein A 
(Amersham Corp.) used at a concentration  of 5-10 uCi in 30 ml of incubation 
buffer. The nitrocellulose paper with the immunolocalized  MEP proteins was 
blotted dry and exposed to x-ray film. The radioactivity  associated with the 
nitrocellulose paper was quantitated  in the same manner as for the gels. 
Immunofluorescence and  Electron Microscopy:  NIH  and 
KNIH cells grown in 35-mm culture dishes were fixed for immunofluorescence 
with 3.7% formaldehyde in PBS for I0 min at 23"C. The cells were then treated 
with  0.1% Triton  X-100  in  PBS  for~3 min at  23"C, washed  in  PBS, and 
incubated  in the "EGS" diluent  (24) composed  of 0.1% saponin,  4  mg/ml 
normal goat globulin,  and  1 mM  EGTA-PBS (sap-NGG-PBS) for  10  min. 
Affinity-purified rabbit anti-MEP  was then added  at 50 #g/ml in sap-NGG- 
PBS for 15 min at 23"C. The cells were washed in PBS and then incubated in 
affinity-purified  goat  anti-rabbit  IgG  conjugated  to  rhodamine  (Jackson 
ImmunoResearch)  in  sap-NGG-PBS  for an additional  15  min.  After being 
washed in PBS, the cells were mounted under a circular (No.  1) coverslip in 
glycerol, viewed with a Zeiss standard  microscope equipped  with a 63X, oil 
(NA  1.4) planapochromat objective with  rhodamine  epifluorescence optics, 
and photographed  on Kodak Tri-X film which was developed in Diafine. For 
electron microscopic immunocytochemistry,  NIH and KNIH ceils were fixed 
and processed using the EGS procedure (24) with 0.2% glutaraldehyde in the 
primary fixative. MEP was localized with affinity-purified rabbit anti-MEP at 
50  ~g/ml  in  Sap-NGG-PBS using  the  ferritin  bridge  sequence  (24). After 
antibody incubations  and postfixation in glutaraldehyde and OsO4, the dishes 
were dehydrated with ethanol and embedded in Epon 812. Thin sections were 
counterstained with lead citrate and bismuth subnitrate as previously described 
(24) and viewed at 50 kV. Controls included the use of an equivalent amount 
of normal rabbit globulin in the first step of the ferritin bridge or immunoflu- 
orescence sequence, and they were uniformly negative. 
RESULTS 
MEP Is Processed into Two'Lower Molecular 
Weight Forms Intracellularly 
Immunoprecipitation of MEP from extracts of cells labeled 
with [3SS]methionine for >1  h reveals  three major forms of 
this protein in KNIH (11) and NIH cells. These proteins have 
molecular weights of 39,000,  29,000,  and 20,000  as deter- 
mined by their migration in SDS polyacrylamide gels using 
several  gel  concentrations  and  BSA,  ovalbumin,  carbonic 
anhydrase, and lysozyme as protein standards. The molecular weights reported here are slightly different from those pub- 
lished earlier (5,  l 1). Previous molecular weight values were 
based on behavior in gels that contained glycerol and linear 
acrylamide, which may have affected our estimation of mo- 
lecular weight. 
We performed pulse-chase experiments labeling with [35S]- 
methionine and [35S]cysteine to evaluate the possible precur- 
sor-product relationship of these three forms of MEP. When 
[35S]cysteine was used as a metabolic label, a clear sequential 
appearance of the three major forms of MEP was observed in 
both cell types. Fig.  1 shows the pulse-chase analysis of [35S]- 
cysteine-labeled  MEP in KNIH cells and Fig. 2 shows a similar 
experiment with NIH cells. In the experiment with the KNIH 
cells, -52% of the [35S]cysteine-containing  MEP was secreted 
and 45% was unaccounted for by the autoradiographic band 
densities by the end of the experiment (Fig.  I a). In both this 
experiment with [35S]cysteine labeling and the one with [35S]- 
methionine labeling (data not shown), there was a rapid loss 
of labeled MEP immediately after synthesis (within 30 min 
of chase) prior to either secretion or processing, which ac- 
counted for 35 and 40% of [35S]cysteine  - and [35S]methionine- 
labeled MEP, respectively. This loss of label could represent 
processing  of MEP  in  these  cells  to  non-immunoreactive 
forms, early degradation of nascent protein, or sequestering 
of  protein in a cell compartment not extractable by detergent. 
The likely precursor-product relationship of  these three forms 
was clearly demonstrated here with the sequential appearance 
of the 29,000-mol-wt form and  finally the relatively stable 
20,000-mol-wt  form.  [35S]Cysteine pulse-chase  labeling  of 
NIH cells (Fig. 2) also demonstrated processing of  the 39,000- 
mol-wt MEP protein similar to the 29,000- and 20,000-mol- 
wt  cellular  forms.  The  high  molecular  weight  bands 
(~200,000) are fibronectin bands that bind nonspecifically to 
S. aureus. By using the graphic representation of the cysteine 
pulse-chase  labeling  in  both  cell  types  (Figs.  I c  and  2c), 
approximate rates of interconversion of the MEP forms can 
be assessed.  NIH  cells  processed the two  lower molecular 
weight proteins more slowly.  The 29,000-mol-wt form ap- 
peared at the same rate but it took 75  min for half of the 
29,000-mol-wt form to be processed to the  20,000-mol-wt 
form in NIH cells whereas it took only ~45  rain in KNIH 
cells. This was reflected in a  longer time to reach maximal 
levels of the 20,000-mol-wt form in nontransformed cells (6 
h  vs.  3  h  in KNIH cells).  The time to degrade half of the 
FIGURE  1  Kinetics  of  processing  [3SS]cysteine-labeled  MEP  in 
KNIH cells. (a) Fluorogram of a 10% acrylamide gel of radiolabeled 
immunoprecipitates from KNIH cell extracts. The cells were plated 
in six-well multiwell dishes at 10  s cells/well 2 d before the experi- 
ment,  pulse-labeled for  15  min at  37°C,  and then  incubated in 
chase medium for the indicated times. Approximately 105 trichlo- 
roacetic acid-precipitable counts from the pulse cell sample (50% 
of total incorporated counts) and equivalent volumes of the other 
cell samples were incubated with the antibody. (b) Fluorogram of 
a  10%  acrylamide gel of  radiolabeled immunoprecipitates from 
KNIH cell media. The cells were treated as described above and 
10% of the total medium volume was imrnunoprecipitated, Molec- 
ular weights in a and b are in thousands. (c) Plot of autoradiographic 
band density (as peak area) versus time of chase. The plot shows 
the presence of the various forms of MEP: cellular 39,000-mol-wt 
MEP (O-O-O), secreted 39,000-mol-wt MEP (O.-.O.- .O), cellular 
29,000-mol-wt MEP (O- -O- -O), and cellular 20,000-mol-wt MEP 
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cells whereas in NIH cells we observed little or no degradation 
of this protein during the time of chase (compare Figs.  1  c and 
2c).  We did  not observe the early large loss of total MEP- 
incorporated radioactivity with the NIH cells that we observed 
with the KNIH cells. 
12 
In  the  [35S]methionine  pulse-chase  labeling  experiments 
(data not shown), we found that ~60%  of the label initially 
incorporated into the 39,000-mol-wt MEP was secreted into 
the medium in KNIH cells compared with only 5% in NIH 
cells. Some of the labeled MEP remaining within the cell was 
converted to  the  two  lower molecular weight  species,  and 
some of the original methionine label was not recovered as 
immunoprecipitable protein in both cell types. 
Tryptic peptide  maps of the  three  intracellular  forms of 
MEP (Fig.  3) demonstrate that the earliest form of MEP seen 
within the cells has the same peptide map as that previously 
published for secreted MEP (10), while the two lower molec- 
ular  weight  forms contain  only  a  few of the  methionine- 
containing peptides seen in  the  secreted form.  [35S]methio- 
nine-labeled  maps of both  nascent  (Fig.  3a)  and  secreted 
MEP (10) show four major labeled peptides in the lower right 
of the map with many spots to the left and above these spots. 
The two lower molecular weight forms have many peptides 
in  common  with  each  other  and  contain  a  subset  of the 
peptides seen in the 39,000-mol-wt dalton protein. As seen in 
Fig. 3, b and c, the 29,000- and 20,000-mol-wt forms of MEP 
are missing three of the heavily labeled spots seen in the map 
of the 39,000-mol-wt precursor. Presumably, those [35S]me- 
thionine-containing peptides are lost in  the  processing that 
takes place to form the 29,000- and 20,000-mol-wt proteins. 
When tryptic peptides from the 39,000-mol-wt cellular form 
and the 29,000-mol-wt form were mixed in ratios of l: 1 and 
1:3 (not shown),  we found no major additional  spots com- 
pared with  those in  the  map of the  39,000-mol-wt protein 
alone. These results indicate that the 29,000- and 20,000-mol- 
wt  forms  of MEP  are  probably  cleavage  products  of the 
39,000-mol-wt MEP and that a  methionine-rich  portion of 
the  MEP  molecule  is  removed by  processing.  The  tryptic 
peptide map of the  39,000-mol-wt cellular MEP from NIH 
cells (Fig.  3 d) is very similar to the KNIH cell protein. This 
indicates no gross differences in the structures of  these proteins 
in NIH cells compared with KNIH cells. 
Short pulses with  [35S]cysteine were performed to try to 
detect  a  precursor  of the  39,000-mol-wt  form of MEP  in 
KNIH cells.  No immunoprecipitable protein with higher or 
lower molecular weight was observed in pulses as short as 30 
s  (Fig.  4).  The  band  of slightly  higher  molecular  weight 
(42,000) observed in many of the immunoprecipitations (e.g., 
Fig.  l) probably does not represent a precursor but is more 
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FIGURE  2  Kinetics of processing [3SS]cysteine-labeled MEP in NIH 
cells.  (a)  Fluorogram  of  a  10%  acrylamide gel  of  radiolabeled 
immunoprecipitates from NIH cell extracts.  The cells were plated 
in  six-well multiwell dishes  at 2  x  104 cells/well 4  d  before the 
experiment, pulse-labeled for 15 min at 37°C, and then incubated 
in chase  medium for the indicated times. Approximately 5 x  104 
trichloroacetic acid-precipitable  counts from the pulse cell sample 
(30% of total incorporated counts)  and equivalent volumes of the 
other cell samples were incubated with the antibody. (b) Fluoro- 
gram of a 10% acrylamide gel of radiolabeled immunoprecipitates 
from  NIH  cell media. The cells  were treated as described above 
and  30% of the total medium volume was immunoprecipitated. 
Molecular weights in a and b are in thousands.  (c)  Plot of autora- 
diographic band density (as peak area) versus time of chase. The 
plot  shows  the  presence of  the  various  forms  of  MEP: cellular 
39,000-mol-wt MEP (O-O-O), secreted 39,000-mol-wt MEP (O.-. 
O.-.O),  cellular  29,000-mol-wt  MEP  (O_-O--O),  and  cellular 
20,000-mol-wt MEP (O .... O .... O)- FIGURE 3  Two-dimensional tryptic peptide analysis of [3SS]methi- 
onine-labeled peptides of various  forms  of MEP: cellular 39,000- 
mol-wt MEP (a), cellular 29,000-mol-wt MEP (b), cellular 20,000- 
mol-wt MEP (c) from KNIH cells, and cellular 39,000-mol-wt MEP 
from  NIH  cells  (d).  The  samples  were  electrophoresed in  the 
horizontal direction with the cathode to the right  and then chro- 
matographed vertically.  The arrowheads indicate corresponding 
peptides in the four maps. 
likely a  differently glycosylated form. This protein has the 
same  tryptic map  as  the  39,000-mol-wt  form (10)  and  is 
present in the same ratio to the amount of 39,000-mol-wt 
protein throughout the short pulse labeling with [35S]cysteine. 
This form of MEP  represents only a  small fraction of the 
steady-state concentration of cellular MEP,  as  seen in  the 
Western blot (Fig. 5, lane a). 
Steady-state levels of MEP proteins within KNIH and NIH 
cells were quantitated by analysis of Western blot patterns in 
total cell extracts (Fig.  5). As the assay is not strictly quanti- 
tative  with  respect  to  the  protein  bound,  the  amount  of 
antibody binding to each of the MEP forms can only be used 
to approximate the amount of the form present. From this 
type of analysis,  we observed a very different distribution of 
MEP forms in the two cell types. KNIH cells were found to 
contain  primarily the  20,000-  and  39,000-mol-wt proteins 
and relatively little of the 29,000-mol-wt form (Fig.  5, lanes 
a-d).  Pulse-chase labeling showed that the middle form is 
more stable in NIH cells, and we observed a higher relative 
amount of  this protein in these cells by Western analysis (Fig. 
5, lanes e-h).  Total MEP levels  within NIH cells were ap- 
proximately one  fourth  that  in  KNIH  cells  for the  same 
number of cells or amount of cell protein. 
Subcellular Localization  of MEP by Density 
Gradient Fractionation 
Disrupted cells were fractionated on a self-forming Percoll 
gradient, and the fractions were analyzed for/3-galactosidase 
activity and  galactosyl transferase activity to  localize lyso- 
somes and Golgi apparatus, respectively (KNIH cells in Fig. 
6a and NIH cells  in  Fig.  7a).  We found three areas of #- 
galactosidase  activity in  both gradients,  the  least  dense of 
which  can  be  attributed  to  soluble  enzyme  from  broken 
organelles (18).  Similar profiles were obtained for both cell 
types with two other lysosomal enzymes, a-glucuronidase and 
a-galactosidase (data not shown). We observed a single peak 
of galactosyl transferase activity which co-sedimented with 
the lighter lysosomal enzyme activity in the gradients from 
KNIH and NIH cells. We observed a relative distribution of 
the lysosomal enzyme marker/~-galactosidase in KNIH cells 
that was different from that observed in NIH cells.  KNIH 
cells show a majority of intact organelle enzymatic activity in 
the light lysosomal or Golgi peak while most of the activity 
in NIH cells sediments with the heavy lysosomal peak (com- 
pare Figs. 6 a and 7 a). Approximately 70% of the total intact 
/~-galactosidase activity is associated with the light lysosomal 
peak in KNIH cells while only 40% is observed to sediment 
in that region in NIH cells. This difference is also seen in the 
distribution of the activities of the two other lysosomal en- 
zymes (data not shown). 
Samples from gradient fractions were electrophoresed on 
SDS polyacrylamide denaturing gels, transferred to nitrocel- 
lulose paper, and localized with an affinity-purified antibody 
FIGURE 4  Kinetics  of the 
appearance  of  39,000- 
mol-wt  cellular MEP. Im- 
munoprecipitates of [3ss]- 
cysteine - radiolabeled 
KNIH  cell  extracts  were 
electrophoresed in a  10% 
acrylamide gel.  A  fluoro- 
gram  is  shown.  The cells 
were pulsed  with  labeling 
medium for 30 s (lane a), 1 
rain  (lane  b),  2  rain  (lane 
c),  5 min (lane d),  and  15 
min  (lane  e).  Approxi- 
mately 3  x  104 trichloro- 
acetic  acid-precipitable 
counts  from  the  15-rain 
pulse sample  (50% of the 
sample) and equal volumes 
of the other extracts were 
incubated  with  the  anti- 
body. 
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tion of MEP forms in KNIH and N IH 
cells. This autoradiogram  shows the 
steady-state  distribution  of  MEP 
forms in KNIH (lanes a-d) and NIH 
cells  (lanes  e-h).  Total  protein 
loaded: lane a (6 x  104 cells) and 
lane e (7 x  104 cells), 20 ~.g; lanes 
b and f, 10 #g; lanes c and g, 5 #g; 
lanes d and  h, 2.5 #g. 39, 39,000; 
29, 29,000; 20, 20,000. 
FIGURE 6  Percoll gradient of KNIH cell extracts. (a) 
The enzymatic and density profile of the gradient. 
Lysosomes  were localized  by/3-galactosidase activity 
and Golgi elements by galactosyl transferase activity. 
Density  marker  beads (Pharmacia Fine Chemicals) 
were used to determine the density profile of the 
gradient. (b) Western  blot localization  of MEP in the 
gradient fractions. Approximately  25 #1 of each frac- 
tion (labeled by fraction number)  and the loading 
sample (S) were electrophoresed on a  10% acryl- 
amide gel, electrolytically transferred  to nitrocellu- 
lose, and  localized with anti-MEP  antibody as de- 
scribed  in  Materials  and  Methods. The molecular 
weight of the  bands  is  indicated at  the side.  39, 
39,000; 29, 29,000; 20, 20,000. 
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FIGURE  7  Percoll gradient of NIH cell extracts.  (a) The enzymatic 
and density profile of the gradient. Lysosomes were localized by/~- 
galactosidase activity and Golgi elements by galactosyl  transferase 
activity. Density marker  beads (Pharmacia,  Inc.) were used to de- 
termine the density profile of the gradient.  (b) Western blot local- 
ization of MEP  in the gradient fractions.  Approximately 25 #1  of 
each fraction (labeled by fraction number) and the loading sample 
(S) were electrophoresed on a 10% acrylamide gel, electrolytically 
transferred  to nitrocellulose, and localized with anti-MEP antibody 
as described  in Materials and Methods. The molecular weight of 
the bands is indicated at the side in thousands. 
against the secreted form of MEP (KNIH cells in Fig. 6 b and 
NIH cells in  Fig.  7b).  This technique measures steady-state 
levels of the various forms of MEP since we use ~25I-protein 
A  to  localize anti-MEP  antibody.  MEP  appeared in  three 
peaks on both gradients at the same densities as #-galactosid- 
ase activity, the lysosomal marker. We also observed a differ- 
ence in  the  localization of the various forms of MEP.  The 
lighter lysosomal/Golgi peak was enriched in the 39,000- and 
20,000-mol-wt  forms of MEP  in  the  gradients  using  both 
KNIH  and  NIH  cells,  whereas  the  heavier  peak  showed 
enrichment in the lowest molecular weight forms. The 29,000- 
mol-wt  protein  is  a  minor  component  of the  steady-state 
cellular pool of MEP in KNIH cells.  In NIH cells,  a greater 
proportion of the MEP was in the 29,000-mol-wt form and it 
was definitely enriched in the heavy lysosomal peak as was 
the  20,000-mol-wt  protein.  The  background  on  the  NIH 
Western  blot was much greater than  on  a  similar blot  for 
KNIH cells because these cells have much lower amounts of 
MEP. The band above the MEP bands in Fig.  7 b (~60,000- 
mol-wt) represents nonspecific localization of '25I-protein A. 
Immunofluorescence and Electron Microscopic 
Localization of MEP 
Fig. 8, A and B shows the immunofluorescence localization 
of MEP in  NIH (Fig.  8A) and  KNIH (Fig.  8B) cells.  The 
predominant pattern in NIH cells appears as punctate intra- 
cellular spots compatible with the distribution of lysosomes, 
in addition to a bright cytoplasmic fluorescence slightly con- 
centrated  in  the  perinuclear region.  The  pattern  in  KNIH 
cells shows  the  punctate  arrangement,  but  this  is  partially 
obscured by a  brighter cytoplasmic localization particularly 
concentrated in an eccentric location in the perinuclear area 
compatible with parts of the Golgi system. By electron micro- 
scopic  immunocytochemistry (Fig.  8,  C-F), MEP  in  NIH 
cells was found to be most concentrated in mature lysosomes 
(Fig. 8 E), with a smaller concentration in the trans elements 
of the Golgi stacks (Fig.  8 C). A  similar pattern was seen in 
KNIH cells,  but the  concentrations were greater (Fig.  8,  D 
and F). In addition, lower concentrations of label were seen 
in  the  nuclear  envelope,  endoplasmic  reticulum,  and  the 
transreticular elements of the Golgi apparatus (not  shown). 
The overall amount of MEP detected inside NIH cells was 
less than that seen in KNIH cells, consistent with biochemical 
measurements.  An  unexplained  low level of specific back- 
ground localization was also seen in both cell types diffusely 
distributed  in  the  extramembranous cytoplasm.  The  same 
distribution  of ferritin  granules was seen  using an  affinity- 
purified antibody prepared from antiserum from a  different 
rabbit. Normal globulin controls showed very low nonspecific 
levels of localization (data not shown). 
DISCUSSION 
The major excreted protein of  transformed mouse cells (MEP) 
is a  39,000-mol-wt phosphoglycoprotein whose  synthesis is 
also enhanced  by growth factors and tumor promoters. We 
have found that within mouse cells there are several forms of 
MEP that cross-react with a polyclonal antibody made against 
the protein excreted by transformed cells. One major form of 
MEP has the same molecular weight as the secreted form and 
the same tryptic map, and thus is presumed to be part of the 
intracellular pool of MEP either not secreted or just prior to 
secretion. Very short pulse labeling (30 s) shows no immu- 
noreactive precursor form of molecular weight >39,000 prior 
to the  appearance of the  39,000-mol-wt  protein.  Since  the 
primary translation product of MEP is immunoreactive and 
has a molecular weight lower by several thousand than MEP 
(6),  it seems reasonable to assume from these data that gly- 
cosylation of MEP in living cells is a co-translational event. 
Two  other  cellular  forms  of MEP  have  lower  molecular 
weights and similar but simpler tryptic maps. The pulse-chase 
labeling experiments described in this paper indicate that these 
proteins are processed forms of cellular MEP. 
Both transformed and nontransformed mouse cells used in 
this study contain MEP as precursor and processed forms. By 
GAL ET AL,  Processing  and Localization of a Major  Excreted  Protein  541 FIGURE  8  Immunocytochemical localization of MEP.  NIH  (A, C, and E) and KNIH  (B, D, and F) cells were fixed and processed 
as  described  in  Materials  and  Methods.  MEP  was  localized  using  immunofluorescence  (A  and  B)  or  electron  microscopic 
immunocytochemistry using the  EGS and ferritin  bridge procedures (C-F). The immunofluorescence pattern in  NIH  cells (A)  is 
predominantly punctate (lysosomal} with  some perinuclear concentration; the  pattern in  KNIH  cells (B)  is  brighter with  some 
punctate elements, but the main pattern is a perinuclear eccentric location (arrow) consistent with elements of the Golgi complex. 
The electron microscopic pattern in  both cell types shows trans-Golgi  concentration (arrows), which  is more concentrated  in 
KNIH cells (D) than in NIH cells (C).  Both cell types show high concentrations of labeling in lysosomes (arrows, E and F) Bars, 10 
~m (A and B); 0.1  gm (C-F). (A and B) x  577; (C-F) x  90,000. 
542 tryptic peptide analysis, the precursor forms in both cell types 
appear very similar (compare Fig.  3, a  and d).  In both cell 
types, the immunoreactive proteins can be localized to the 
same organelles as lysosomal proteins with biochemical and 
microscopic assays. Yet, there are major differences between 
the transformed and  nontransformed cells:  (a) KNIH cells 
synthesize 50-fold more total MEP than NIH cells and secrete 
50-60%  of the  39,000-mol-wt  protein  made vs.  5-28%  in 
NIH cells: (b) there is four- to fivefold more MEP in KNIH 
cells than  in  NIH cells and the  relative distribution  of the 
various forms of MEP is also different; and (c) in KNIH cells, 
70%  of lysosomal enzyme  activity  sediments  in  the  light 
lysosomal/Golgi fraction whereas the majority (~60%) of the 
activity for NIH cells sediments in the heavy lysosomal peak. 
The distribution of lysosomal enzyme activity seen with CHO 
(25)  cells is similar to the distribution  for NIH cells.  These 
data suggest that there is a general difference in the way KNIH 
cells handle lysosomal enzymes compared with NIH cells as 
well as specific differences in how MEP is regulated in these 
cell types. 
The data presented here and in a  previous paper (11)  are 
consistent with the view that MEP is a lysosomal protein. We 
previously showed (11) that the  secreted MEP from KNIH 
cells contains the mannose 6-phosphate recognition marker 
and binds to the  mannose 6-phosphate receptor that is in- 
volved in the shuttling of lysosomal enzymes in the cell (12). 
In this study, we have shown by two different methods, Percoll 
gradient fractionation and immunofluorescence and electron 
microscopic localization, that cellular MEP localizes to lyso- 
somes and the Golgi apparatus in the same manner as lyso- 
somal enzymes. The putative precursor form of MEP (39,000 
mol wt) is found in the light lysosomal peak but not in the 
denser one, while the two processed forms (29,000 and 20,00 
mol wt) are  found  in  both  the  heavy and  light  lysosomal 
fractions.  This  is consistent  with  the  localization  of other 
precursor and processed forms oflysosomal enzymes such as 
cathepsin D  and ~-hexosaminidase (26).  These data do not 
allow us to determine whether processing of MEP precedes 
its appearance in the lysosomal fraction or occurs after migra- 
tion to the lysosomes. 
We considered the possibility that the MEP "processing" in 
KNIH cells observed in this work might simply be the deg- 
radation of the secreted form following its reuptake via man- 
nose 6-phosphate receptors and delivery to lysosomes. This 
possibility is ruled out by the observation (data not shown) 
that the lower molecular weight forms of MEP appear in cells 
labeled in medium that contains 5 mM mannose 6-phosphate 
which blocks the binding of MEP to the mannose 6-phosphate 
receptor (11 ). 
The work described above suggests that MEP in nontrans- 
formed cells  is a  fairly typical lysosomal protein.  However, 
there  are  two  observations that  are  not  entirely consistent 
with  MEP  being  a  typical  lysosomal protein.  Despite  the 
ability  of MEP  to  bind  to  purified  mannose  6-phosphate 
receptor, it is not taken up with 100% efficiency by CHO cells 
(11). This result is in contrast to that found with B-galactosid- 
ase from KNIH cells whose secretion can be stimulated by 
NH4CI treatment. This B-galactosidase is efficiently endocy- 
tosed by CHO cells and processed normally (11). Second, 50- 
60% of the 39,000-mol-wt form of MEP is secreted by KNIH 
cells even in the absence of NH4CI. Thus, it appears that a 
fraction of MEP is selectively segregated from the lysosomal 
enzyme pool and secreted in these transformed cells despite 
the binding of this protein to the phosphomannosyl receptor 
(ll). 
Intmcellulafly packaged  proteins  such  as  lysosomal en- 
zymes and secreted proteins are synthesized in rough endo- 
plasmic reticulum, processed in the Golgi stacks, and segre- 
gated in vesicles that bud off of the Golgi complex. At some 
point  along  this  pathway,  the  two  types of proteins  must 
diverge since their eventual destinations, lysosomes or secre- 
tory vesicles, are morphologically and biochemically distinct. 
Little is known about the mechanism or signal for this segre- 
gation. Mannose 6-phosphate is believed to be the marker for 
proteins destined to reside in lysosomes; however in the case 
of MEP  this  signal  may not  be sufficient  or  may not  be 
properly displayed on the surface of the protein, or another 
signal may disrupt this segregation in KNIH cells. Uteroferrin, 
a  secreted  lysosomal protein,  has a  "covered" mannose 6- 
phosphate which may explain the routing oftbe secreted form 
to the cell  surface (27).  There is also evidence from several 
laboratories that  the  mannose 6-phosphate receptor system 
may not be sufficient for delivery of acid hydrolases to lyso- 
somes in some cell types. Patients with I-cell disease lack the 
enzyme required to form the mannose 6-phosphate moiety 
on lysosomal proteins (28,  29). As a consequence, fibroblasts 
from these  patients  secrete their  acid  hydrolases  (30).  But 
other types of cells in the same patients, such as hepatocytes, 
Kupffer cells, and leukocytes, contain nearly normal levels of 
lysosomal enzymes (31,  32).  Work by Gabel et al. (33) with 
murine macrophage mutants and by Robbins and Myerowitz 
(34) with CHO cell mutants with reduced levels of the man- 
nose 6-phosphate receptor show that these mutant cells con- 
tain  significant  levels of acid  hydrolases within  their  lyso- 
somes. An alteration in a routing mechanism other than the 
one requiring mannose 6-phosphate may explain the secretion 
of MEP in KNIH cells. By studying a protein that has prop- 
erties of both secreted and lysosomal proteins, such as MEP, 
more may be revealed about the mechanism of this segrega- 
tion. 
The correlation of MEP synthesis and secretion with trans- 
formation is another  intriguing  aspect of our study.  Lyso- 
somes contain proteins with activities that could be involved 
in  local  invasion  of tumors,  metastasis,  or  tumor  related 
syndromes. These lysosomal enzyme activities include phos- 
pholipases (35), neuraminidases (36), hyaluronidase (37), col- 
lagenase (38),  and various proteases (39-41).  Sloan and co- 
workers (42) have found that the lysosomal protease cathepsin 
B  may  be  correlated  wtih  transformation.  These  workers 
observed a relationship between metastatic potential in B l6 
melanoma cells and cathepsin B activity in tumor homoge- 
nates. We are continuing to search for an enzymatic activity 
associated with MEP and are now cognizant of the possibility 
that the activity may reside only in the processed forms of 
this protein. 
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